Cart (0 Items)
Your cart is currently empty.
View Products 
               
               
               
              | Size | 100ug, 1MG | 
|---|---|
| Isotype | IgG2, kappa | 
| Brand | ProteoGenix | 
| Product type | Primary Antibodies | 
| Clonality | Monoclonal Antibody | 
| Expression system | Mammalian cells | 
| Applications | Elisa, WB | 
| Product name | Bococizumab Biosimilar - Anti-PCSK9, NARC1, PC9 mAb - Research Grade | 
|---|---|
| Source | CAS 1407495-02-6 | 
| Species | Humanized | 
| Purity | >85% | 
| Buffer | PBS buffer PH7.5 | 
| Delivery condition | Blue ice (+4°C) | 
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed | 
| Storage condition | store at -80°C | 
| Brand | ProteoGenix | 
| Aliases /Synonyms | Bococizumab,PF-04950615,RN-316,PCSK9, NARC1, PC9,anti-PCSK9, NARC1, PC9 | 
| Reference | PX-TA1341 | 
| Note | For research use only. Not suitable for clinical or therapeutic use. | 
| Isotype | IgG2-kappa | 
| Clonality | Monoclonal Antibody | 
Bococizumab has been investigated for the treatment and prevention of Dyslipidemia, Hyperlipidemia, Hypercholesterolemia, Cardiovascular Disease, and Heterozygous Familial Hypercholesterolemia.
 
                Bococizumab Biosimilar - Anti-PCSK9, NARC1, PC9 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Send us a message from the form below
Reviews
There are no reviews yet.